Document is current
Any future updates will be listed below
-
Authors
Edstorp, Jessica https://orcid.org/0000-0002-6009-8738
Rossides, Marios https://orcid.org/0000-0002-9769-324X
Ahlqvist, Emma https://orcid.org/0000-0002-6513-2384
Alfredsson, Lars https://orcid.org/0000-0003-1688-6697
Askling, Johan https://orcid.org/0000-0003-0433-0616
Di Giuseppe, Daniela https://orcid.org/0000-0003-3817-8288
Grill, Valdemar https://orcid.org/0000-0001-6959-022X
Sorgjerd, Elin P. https://orcid.org/0000-0002-5995-2386
Tuomi, Tiinamaija https://orcid.org/0000-0002-8306-6202
Åsvold, Bjørn O. https://orcid.org/0000-0003-3837-2101
Carlsson, Sofia https://orcid.org/0000-0002-9497-2331
-
Funding
Funding for this research was provided by:
Lund University Medical Faculty Foundation
Vetenskapsrådet (2018-03035, 2020-02191)
Crafoordska Stiftelsen
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2018-00337)
Swedish governmental funding of clinical research
Vinnova Swelife
Direktör Albert Påhlssons Stiftelse
Diabetesfonden
Swedish Foundation for Strategic Research (IRC15-0067)
Bo and Kerstin Hjelt Diabetes Foundation
Novo Nordisk Fonden (NNF19OC0057274, NNF21OC0070457)
exodiab (2009-1039)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 29 April 2024
Accepted: 17 September 2024
First Online: 28 October 2024
Acknowledgements
: We thank the participants in ESTRID and HUNT, as well as the administrative personnel, nurses and research team members.
: The de-identified datasets generated and analysed in the current study are available from the corresponding author on reasonable request (ESTRID) and with permission of the HUNT study by applying to the HUNT study data access committee.
: The ESTRID study was funded by grants from the Swedish Research Council (2018-03035), Research Council for Health, Working Life and Welfare (FORTE, 2018-00337), Novo Nordisk Foundation (NNF19OC0057274) and Swedish Diabetes Foundation. The ANDIS study was financed by Swedish governmental funding of clinical research (ALF), the Faculty of Medicine at Lund University, the Swedish Research Council (project grant no. 2020-02191 and strategic research area grant no. 2009-1039 [EXODIAB]), the Swedish Foundation for Strategic Research (IRC15-0067 [LUDC-IRC]) and Vinnova Swelife. EA was also funded by the Novo Nordisk Foundation (grant no. NNF21OC0070457), the Crafoord Foundation, the Bo & Kerstin Hjelt Diabetes Foundation and the Albert Påhlsson Foundation. The Trøndelag Health Study (HUNT) is a collaboration between the HUNT Research Centre (Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology), Trøndelag County Council, the Central Norway Regional Health Authority and the Norwegian Institute of Public Health.
: The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
: SC, MR and JE contributed to the conception and design of the work. EA, LA, JA, DDG, VG, EPS, TT and BOA contributed to the acquisition of data. JE performed the analyses. All authors contributed to the interpretation of data. JE drafted the article and all authors edited, reviewed and approved the final version to be published. JE is responsible for the integrity of this work as a whole.
